Oligo-Fucoidan improved skin health in in vitro and clinical study
Phase 1
Completed
- Conditions
- skin sub-health personskin dysfunction
- Registration Number
- TCTR20220623004
- Lead Sponsor
- Hi-Q Marine Biotech International Ltd
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Female
- Target Recruitment
- 80
Inclusion Criteria
female subjects, between 30 and 60 years of age
Exclusion Criteria
Serious skin disease, skin wounds, skin cancer
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method oligo-fucoidan inhibits inflammation At 0, 24, 48, 72, 96 and 120 h The levels of inflammatory cytokines assay, oligo-fucoidan inhibits the number of wrinkles after 14 days oligo-fucoidan inhibits
- Secondary Outcome Measures
Name Time Method oligo-fucoidan increased collagen production after 14 days skin ultrasound analyzer